KELLY FRANK: Open Payments
NPI 1457130114 · YARDLEY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,545 in 58 payments from 13 companies in 2025. Trend: 2023 $125 · 2024 $1,104 · 2025 $1,545
Food & beverage: $1,545
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $367 |
| ABBVIE INC. | 14 | $255 |
| Novo Nordisk Inc | 7 | $231 |
| Otsuka America Pharmaceutical, Inc. | 3 | $145 |
| Janssen Pharmaceuticals, Inc | 4 | $123 |
| Exact Sciences Corporation | 6 | $103 |
| Lilly USA, LLC | 5 | $89 |
| PFIZER INC. | 3 | $59 |
| Amgen Inc. | 2 | $56 |
| Bausch Health US, LLC | 2 | $42 |
Products named: AIRSUPRA, REXULTI, Ozempic, UBRELVY, SPRAVATO, VRAYLAR, MOUNJARO, PREVNAR 20.
Industry payments across PA — which companies pay providers there.
